NEUROGESX INC

Profile

Company Names

NEUROGESX INC

Addresses

999 BAKER WAY SUITE 200, SAN MATEO, CA 94404

2215 BRIDEGPOINTE PARKWAY, SUITE 200, SAN MATEO, CA 94404

2215 BRIDGEPOINT PARKWAY, SUITE 200, SAN MATEO, CA 94404

2215 BRIDGEPOINTE PARKWAY, SUITE 200, SAN MATEO, CA 94404

Phone Numbers

650-358-3304
650-358-3300

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, OTHER HEALTH CARE

Year Incorporated:

> 5 years ago

State Incorporated:

CALIFORNIA

Total Amount Raised:

$26,292,911.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2012-11-12 
$684,300.00 
$684,300.00 
$0.00 
 
4
2012-03-26 
$975,000.00 
$975,000.00 
$0.00 
 
3
2012-02-03 
$2,999,382.00 
$2,999,382.00 
$0.00 
Equity 
2
2011-08-05 
$1,425,000.00 
$1,425,000.00 
$0.00 
 
1
2011-07-26 
$20,209,229.00 
$20,209,229.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEAN-JACQUES 
 
BIENAIME 
DIRECTOR
NEUROGESX INC   |  PORTOLA PHARMACEUTICALS INC   |  VITAL THERAPIES INC
ANTHONY 
 
DITONNO 
DIRECTOR
NEUROGESX INC   |  AVANTIS MEDICAL SYSTEMS INC   |  TENAX THERAPEUTICS, INC.
ANTHONY 
A. 
DITONNO 
EXECUTIVE OFFICER, DIRECTOR
NEUROGESX INC   |  OXYGEN BIOTHERAPEUTICS, INC.
STEPHEN 
F. 
GHIGLIERI 
EXECUTIVE OFFICER
NEUROGESX INC
BRADFORD 
 
GOODWIN 
DIRECTOR
NEUROGESX INC
BRADFORD 
S. 
GOODWIN 
DIRECTOR
NEUROGESX INC
NEIL 
 
KURTZ 
DIRECTOR
NEUROGESX INC   |  VINETI, INC.
NEIL 
M. 
KURTZ 
DIRECTOR
NEUROGESX INC
GARY 
 
LYONS 
DIRECTOR
NEUROGESX INC   |  KALOBIOS PHARMACEUTICALS INC   |  INTERNATIONAL FRONTIER RESOURCES CORP   |  NOVUS THERAPEUTICS, INC.   |  ELEDON PHARMACEUTICALS, INC.
GARY 
A. 
LYONS 
DIRECTOR
NEUROGESX INC   |  NOVUS THERAPEUTICS, INC.
MICHAEL 
 
MARKELS 
EXECUTIVE OFFICER
NEUROGESX INC
MICHAEL 
E. 
MARKELS 
EXECUTIVE OFFICER
NEUROGESX INC
RONALD 
A. 
MARTELL 
EXECUTIVE OFFICER, DIRECTOR
NEUROGESX INC
ROBERT 
 
NELSEN 
DIRECTOR
FORGE INC   |  RECEPTOS, INC. (F.K.A. RECEPTOR PHARMACEUTICALS INC.)   |  AGIOS PHARMACEUTICALS INC   |  KILIMANJARO ENERGY, INC.   |  NEUROGESX INC   |  KYTHERA BIOPHARMACEUTICALS INC   |  SYROS PHARMACEUTICALS, INC.   |  FATE THERAPEUTICS INC   |  CENEXYS, INC.   |  JUNO THERAPEUTICS, INC.   |  BELLEROPHON THERAPEUTICS LLC   |  FARADAY PHARMACEUTICALS, INC.   |  SAPPHIRE ENERGY, INC.   |  UNITY BIOTECHNOLOGY, INC.   |  ARIVALE INC.   |  SIENNA BIOPHARMACEUTICALS, INC.   |  GOSSAMER BIO, INC.   |  VIR BIOTECHNOLOGY, INC.   |  BEAM THERAPEUTICS INC.   |  GRAIL, INC.   |  APEX NEURO HOLDINGS, INC.   |  NUTCRACKER THERAPEUTICS, INC.   |  SANA BIOTECHNOLOGY, INC.   |  INSITRO, INC.   |  NATIONAL RESILIENCE, INC.   |  MEDICAL CREATIONS, INC.   |  NEUMORA THERAPEUTICS, INC.   |  RIPPL CARE, INC.   |  SEAPORT THERAPEUTICS, INC.
ROBERT 
T. 
NELSEN 
DIRECTOR
IKARIA HOLDINGS INC   |  FATE THERAPEUTICS INC   |  NEUROGESX INC   |  SAGE THERAPEUTICS, INC.   |  ARCH VENTURE FUND VIII, L.P.   |  ARCH VENTURE FUND IX, L.P.   |  GRAIL, INC.   |  ARCH VENTURE FUND X, L.P.   |  ARCH VENTURE FUND X OVERAGE, L.P.   |  ARCH VENTURE FUND XI, L.P.   |  ARCH VENTURE FUND XII, L.P.
STEVEN 
 
NELSON 
DIRECTOR
NEUROGESX INC   |  HALO MARITIME DEFENSE SYSTEMS, INC.   |  SCIQUEST INC   |  ARRAY HEALTH SOLUTIONS INC   |  CA RESOURCES FUND (U.S. TAX-EXEMPT), L.P. - SERIES ADVENT INTERNATIONAL GPE VIII   |  CA RESOURCES FUND (U.S. TAX-EXEMPT), L.P. - SERIES THIRD ROCK VENTURES IV   |  DMG PRACTICE MANAGEMENT SOLUTIONS LLC   |  ECOARK HOLDINGS, INC.   |  DARIOHEALTH CORP.   |  PRIME BUCHHOLZ LLC   |  SOUTHEASTERN FIBER CORP
STEVEN 
H. 
NELSON 
DIRECTOR
NEUROGESX INC
JOHN 
 
ORWIN 
DIRECTOR
NEUROGESX INC   |  ATRECA, INC.   |  CARGO THERAPEUTICS, INC.
JOHN 
A. 
ORWIN 
DIRECTOR
NEUROGESX INC
STEPHEN 
 
PEROUTKA 
EXECUTIVE OFFICER
NEUROGESX INC
JEFFREY 
K. 
TOBIAS 
EXECUTIVE OFFICER
NEUROGESX INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-11-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-11-12 
2012-03-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2012-03-26 
2012-02-08
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-02-03 
2011-08-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
 
2011-08-05 
2011-08-03
D
Link
OTHER HEALTH CARE 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2011-07-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LEERINK SWANN LLC
39011